AuB

Ginza, Japan

AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.

May 2024

Series C

Top Investors

Mitsubishi UFJ CapitalShizuoka CapitalKyoceraTaiho PharmaceuticalFundinno

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are AuB's investors?

AuB's investors include Mitsubishi UFJ Capital, Shizuoka Capital, Kyocera, Taiho Pharmaceutical, Fundinno.

Where is AuB headquartered?

AuB is headquartered in Ginza, Japan.

What does AuB do?

AuB is an intestinal microflora analysis that contributes to the athlete's performance improvement and human health maintenance.

What stage is AuB at?

AuB is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 31, 2024.

MLA

"AuB — Funding & Investors." VCBacked, May 31, 2024, https://www.vcbacked.co/company/aub. Accessed July 1, 2026.

APA

VCBacked. (2024). AuB — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/aub

Wikipedia (cite web)

{{cite web |title=AuB — Funding & Investors |url=https://www.vcbacked.co/company/aub |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 31, 2024.